Cervical Cancer in French Guiana: Screening Between 2006-2011 (DepCol)
September 13, 2016 updated by: Centre Hospitalier de Cayenne
Cervical Cancer in French Guiana: Screening Between 2006-2011. Description of the Population With Invasive Cervical Cancer Between 2003-2008
Given that cervical cancer is the second most frequent cancer among women in french guiana the aim of the study was to determine the screening rate among women living in French Guiana.
Cervical smears are read in 2 laboratories which allowed us to compute screening rates per 100 women-years.
overall the screening activity was 23.5-25.8
smears per 100 women-years.
between 2006 and 2011 54% of women were screened.
These baseline figures will allow to evaluate present efforts to increase the screening rate for this frequent cancer in French Guiana.
Study Overview
Study Type
Observational
Enrollment (Actual)
91458
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
French Guiana
-
Cayenne, French Guiana, France, 97306
- Centre Hospitalier de Cayenne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
all women screened for cervical cancer using pap smear
Description
Inclusion Criteria:
- women screened
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cervical cancer screening
Time Frame: 1 year (screening that year)
|
Cytological examination screens for neoplasic lesion according to the Bethsda 2001, results are assessed on a yearly basis to obtain annual screening rates relative to the female population.
|
1 year (screening that year)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
September 6, 2016
First Submitted That Met QC Criteria
September 13, 2016
First Posted (Estimate)
September 16, 2016
Study Record Updates
Last Update Posted (Estimate)
September 16, 2016
Last Update Submitted That Met QC Criteria
September 13, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DepCol
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.